Partial Seizure — Patent Landscape
4
Approved drugs
44
Active US patents
43/100
Avg vulnerability
$700M
Annual revenue covered
Originators in Partial Seizure
Cliff calendar — next 15 years
7
26
12
28
9
30
10
32
6
39
Approved drugs ranked by patent estate
| Drug | Originator | Active patents | Avg vuln | Revenue | First cliff |
|---|---|---|---|---|---|
|
Aptiom
ESLICARBAZEPINE ACETATE
|
Sumitomo Pharma Am | 20 | 50 | — | 2028-09-13 |
|
Xcopri
CENOBAMATE
|
Sk Life | 12 | 37 | — | 2032-10-30 |
|
Fycompa
PERAMPANEL
|
Catalyst Pharms | 7 | 26 | $300M | 2026-07-01 |
|
Briviact
BRIVARACETAM
|
UCB | 5 | 58 | $400M | 2030-04-09 |
Most attackable patents
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 9763954 | Aptiom | method of use | 75 | 2028-09-13 |
| 9763954 | Aptiom | method of use | 75 | 2028-09-13 |
| 9763954 | Aptiom | method of use | 75 | 2028-09-13 |
| 9763954 | Aptiom | method of use | 75 | 2028-09-13 |
| 11654133 | Xcopri | method of use | 70 | 2039-06-16 |
| 11654133 | Xcopri | method of use | 70 | 2039-06-16 |
| 11654133 | Xcopri | method of use | 70 | 2039-06-16 |
| 11654133 | Xcopri | method of use | 70 | 2039-06-16 |
| 11654133 | Xcopri | method of use | 70 | 2039-06-16 |
| 11654133 | Xcopri | method of use | 70 | 2039-06-16 |
Strongest defences
| Patent | Drug | Type | Vuln | Expiry |
|---|---|---|---|---|
| 7598279 | Xcopri | composition of matter | 4 | 2032-10-30 |
| 7598279 | Xcopri | composition of matter | 4 | 2032-10-30 |
| 7598279 | Xcopri | composition of matter | 4 | 2032-10-30 |
| 7598279 | Xcopri | composition of matter | 4 | 2032-10-30 |
| 7598279 | Xcopri | composition of matter | 4 | 2032-10-30 |
| 7598279 | Xcopri | composition of matter | 4 | 2032-10-30 |
| 8772497 | Fycompa | composition of matter | 22 | 2026-07-01 |
| 8772497 | Fycompa | composition of matter | 27 | 2026-07-01 |
| 8772497 | Fycompa | composition of matter | 27 | 2026-07-01 |
| 8772497 | Fycompa | composition of matter | 27 | 2026-07-01 |
Related
- Partial Seizure — full disease profile
- AI Patent Landscape Report — type "partial seizure" for an AI exec memo
- Company Patent Rankings
- Biosimilar Opportunity Scanner